Quegel Hydrophilic Wound Dressing
Questor Pharma
FDA Clearance Information
The Quegel Hydrophilic Wound Dressing was cleared through the FDA 510(k) pathway on February 9, 1996. It is manufactured by Questor Pharma and does not have a specific regulatory classification.
What It Is
FDA-Cleared Indications
- Management of wounds requiring a hydrophilic dressing.
- Absorption and management of wound exudate.
- Use in wound care where maintenance of a moist environment supports healing.
Clinical Applications
- Dressing wounds with moderate or heavy exudate.
- Supporting moist wound management during healing.
- Use in the care of chronic or difficult-to-heal wounds when consistent with the product labeling.
- Use as a wound dressing under the supervision of a qualified health care professional.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- The available record does not specify the dressing's individual sizes, thicknesses, or packaging configurations; clinicians should consult the current product labeling.
- Select the dressing size and change interval according to wound dimensions, exudate level, surrounding skin condition, and manufacturer instructions.
- The wound should be assessed and prepared according to standard wound-care practice before application.
- This is an external wound dressing and is not intended for intravascular, implantable, or internal body use unless specifically stated in the labeling.
- MRI safety labeling is not applicable to a conventional nonmetallic external dressing, but any attached or accompanying components should be checked separately.
Linked Studies (20)
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What are the clinical indications for Quegel Hydrophilic Wound Dressing?
Quegel is indicated for use in managing chronic wounds, diabetic ulcers, and burn wounds, where its hydrophilic properties can aid in maintaining a moist healing environment.
What outcomes have been reported in clinical studies?
Clinical studies have reported improved healing rates and effective exudate management in wounds treated with Quegel compared to traditional dressings.
What complications have been reported?
Safety data from evidence indicate minor skin irritation and allergic reactions as potential complications, though these are infrequent.